Logo image of ALGID.PA

EGIDE (ALGID.PA) Stock Fundamental Analysis

EPA:ALGID - Euronext Paris - Matif - FR0000072373 - Common Stock - Currency: EUR

0.53  -0.01 (-1.85%)

Fundamental Rating

2

Taking everything into account, ALGID scores 2 out of 10 in our fundamental rating. ALGID was compared to 51 industry peers in the Electronic Equipment, Instruments & Components industry. Both the profitability and financial health of ALGID have multiple concerns. ALGID has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ALGID had negative earnings in the past year.
In the past year ALGID had a positive cash flow from operations.
ALGID.PA Yearly Net Income VS EBIT VS OCF VS FCFALGID.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 2M -2M -4M

1.2 Ratios

Looking at the Return On Assets, with a value of -14.15%, ALGID is doing worse than 82.35% of the companies in the same industry.
With a Return On Equity value of -65.00%, ALGID is not doing good in the industry: 82.35% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -14.15%
ROE -65%
ROIC N/A
ROA(3y)-10.17%
ROA(5y)N/A
ROE(3y)-43.03%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALGID.PA Yearly ROA, ROE, ROICALGID.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 -20 -40 -60 -80

1.3 Margins

The Gross Margin of ALGID (60.61%) is better than 74.51% of its industry peers.
In the last couple of years the Gross Margin of ALGID has remained more or less at the same level.
ALGID does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 60.61%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.14%
GM growth 5YN/A
ALGID.PA Yearly Profit, Operating, Gross MarginsALGID.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 20 40 60

More info and screens

1

2. Health

2.1 Basic Checks

ALGID does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALGID has more shares outstanding
Compared to 1 year ago, ALGID has an improved debt to assets ratio.
ALGID.PA Yearly Shares OutstandingALGID.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 5M 10M 15M
ALGID.PA Yearly Total Debt VS Total AssetsALGID.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 5M 10M 15M 20M 25M

2.2 Solvency

Based on the Altman-Z score of 1.15, we must say that ALGID is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.15, ALGID is not doing good in the industry: 74.51% of the companies in the same industry are doing better.
The Debt to FCF ratio of ALGID is 604.53, which is on the high side as it means it would take ALGID, 604.53 years of fcf income to pay off all of its debts.
ALGID has a worse Debt to FCF ratio (604.53) than 66.67% of its industry peers.
A Debt/Equity ratio of 1.01 is on the high side and indicates that ALGID has dependencies on debt financing.
ALGID has a worse Debt to Equity ratio (1.01) than 76.47% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.01
Debt/FCF 604.53
Altman-Z 1.15
ROIC/WACCN/A
WACC7.23%
ALGID.PA Yearly LT Debt VS Equity VS FCFALGID.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 5M -5M 10M

2.3 Liquidity

A Current Ratio of 1.31 indicates that ALGID should not have too much problems paying its short term obligations.
ALGID has a Current ratio of 1.31. This is in the lower half of the industry: ALGID underperforms 64.71% of its industry peers.
ALGID has a Quick Ratio of 1.31. This is a bad value and indicates that ALGID is not financially healthy enough and could expect problems in meeting its short term obligations.
ALGID has a Quick ratio of 0.75. This is in the lower half of the industry: ALGID underperforms 76.47% of its industry peers.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 0.75
ALGID.PA Yearly Current Assets VS Current LiabilitesALGID.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 5M 10M 15M

More info and screens

3

3. Growth

3.1 Past

ALGID shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 63.33%, which is quite impressive.
The Revenue has decreased by -4.87% in the past year.
The Revenue has been growing slightly by 7.00% on average over the past years.
EPS 1Y (TTM)63.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-8%
Revenue 1Y (TTM)-4.87%
Revenue growth 3Y7%
Revenue growth 5YN/A
Sales Q2Q%-19.57%

3.2 Future

The Earnings Per Share is expected to grow by 18.92% on average over the next years. This is quite good.
Based on estimates for the next years, ALGID will show a small growth in Revenue. The Revenue will grow by 1.64% on average per year.
EPS Next Y136.87%
EPS Next 2Y48.85%
EPS Next 3Y23.68%
EPS Next 5Y18.92%
Revenue Next Year4.58%
Revenue Next 2Y13.17%
Revenue Next 3Y0.4%
Revenue Next 5Y1.64%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALGID.PA Yearly Revenue VS EstimatesALGID.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M
ALGID.PA Yearly EPS VS EstimatesALGID.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2022 2024 2025 2026 0 -0.1 -0.2 -0.3

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

ALGID reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 12.80, which indicates a correct valuation of ALGID.
66.67% of the companies in the same industry are more expensive than ALGID, based on the Price/Forward Earnings ratio.
ALGID's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 35.28.
Industry RankSector Rank
PE N/A
Fwd PE 12.8
ALGID.PA Price Earnings VS Forward Price EarningsALGID.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

ALGID's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. ALGID is more expensive than 66.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 546.74
EV/EBITDA N/A
ALGID.PA Per share dataALGID.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

ALGID's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALGID's earnings are expected to grow with 23.68% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y48.85%
EPS Next 3Y23.68%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALGID!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EGIDE

EPA:ALGID (8/7/2025, 7:00:00 PM)

0.53

-0.01 (-1.85%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)04-29 2025-04-29
Earnings (Next)10-20 2025-10-20
Inst Owners11.72%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap10.39M
Analysts86.67
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 12.8
P/S 0.32
P/FCF 546.74
P/OCF 43.83
P/B 1.86
P/tB 1.86
EV/EBITDA N/A
EPS(TTM)-0.22
EYN/A
EPS(NY)0.04
Fwd EY7.81%
FCF(TTM)0
FCFY0.18%
OCF(TTM)0.01
OCFY2.28%
SpS1.68
BVpS0.29
TBVpS0.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.15%
ROE -65%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 60.61%
FCFM 0.06%
ROA(3y)-10.17%
ROA(5y)N/A
ROE(3y)-43.03%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.14%
GM growth 5YN/A
F-Score6
Asset Turnover1.28
Health
Industry RankSector Rank
Debt/Equity 1.01
Debt/FCF 604.53
Debt/EBITDA N/A
Cap/Depr 13.73%
Cap/Sales 0.66%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.31
Quick Ratio 0.75
Altman-Z 1.15
F-Score6
WACC7.23%
ROIC/WACCN/A
Cap/Depr(3y)327.32%
Cap/Depr(5y)N/A
Cap/Sales(3y)3%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)63.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-8%
EPS Next Y136.87%
EPS Next 2Y48.85%
EPS Next 3Y23.68%
EPS Next 5Y18.92%
Revenue 1Y (TTM)-4.87%
Revenue growth 3Y7%
Revenue growth 5YN/A
Sales Q2Q%-19.57%
Revenue Next Year4.58%
Revenue Next 2Y13.17%
Revenue Next 3Y0.4%
Revenue Next 5Y1.64%
EBIT growth 1Y-543.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-99.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-94.56%
OCF growth 3Y-21.26%
OCF growth 5YN/A